HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the opportunity to provide comments on the U.S. Drug Enforcement Administration’s (DEA) proposed aggregate production quotas for Schedule I and II controlled substances.
HSCA represents the nation’s leading healthcare group purchasing organizations (GPOs), the sourcing and purchasing partners to virtually all of America’s 7,000+ hospitals, as well as the vast majority of the 68,000+ long-term care facilities, surgery centers, clinics, and other healthcare providers.
Related Posts
Comments of the Healthcare Supply Chain Association (HSCA) to FDA on Facilitating Competition and Innovation in the Biological Products Marketplace
On behalf of the Healthcare Supply Chain Association (HSCA), thank you for the...
HSCA Applauds Senate Judiciary Committee for Advancing the CREATES Act
Washington, DC (June 14, 2018) – Healthcare Supply Chain Association (HSCA)...
HSCA Comments on DEA Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances
On behalf of the Healthcare Supply Chain Association (HSCA), we appreciate the...
HSCA Urges DEA to Take Steps to Mitigate Shortages of Injectable Opioids
Healthcare Supply Chain Association (HSCA) President and CEO Todd Ebert, R.Ph.,...